Immediate Impact

6 hit
Sub-graph 1 of 3

Citing Papers

Size‐Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting
2019 Hit
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
2015 Hit

Works of Maria Kissel being referenced

Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma
2013
Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers
2005
Rankless by CCL
2026